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ABSTRACT 
It is currently a major scientific and medical goal to identify and characterize 
genetic defects and their impact in health and disease. For example, mutations in genes 
that encode collagen alpha chains can cause skeletal dysplasia and lead to premature 
degenerative joint disease. Collagen is the main structural protein in the ECM of 
connective tissues such as the cartilage, joints, ligaments and tendons. Therefore, the goal 
of this research is to define the impact of the alpha one chain of collagen type XI chain, 
encoded by the COL11A1 gene in humans, on chondrocyte behavior during development 
of the cartilage. We hypothesize that altered expression of COL11A1 dysregulates 
chondrocyte behavior during cartilage development by altering β-catenin dependent 
signaling pathways. To test this hypothesis, we inhibited the expression of the COL11A1 
homolog col11a1a in transgenic zebrafish expressing green fluorescence protein in neural 
crest derived cells and osteoblast. Then, the col11a1a deficient zebrafish were imaged by 
confocal microscopy to analyze the organization of cells contributing to craniofacial 
development. Inhibiting col11a1a expression reduced the size and shape of the 
developing Meckel’s cartilage in zebrafish. These changes occurred because the cells 
failed to form the hallmark columns that normally promote longitudinal growth. In 
addition, premature and ectopic mineralization was found to occur in the cartilage tissue 
of the Meckel’s cartilage. Additional investigation using the well-established embryonic 
mouse cell line ATDC5 led to the identification of changes in post translational 
modification of proteins which regulate cell behavior. Specifically, the AKT/GSK3β/β-
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catenin proteins were modified to increase the activity of the transcription factor 
TCF/LEF. This activation was coupled to 1) changes in gene expression, 2) decreased 
cartilage growth, and 3) increased mineralization. In conclusion, the results confirm that 
loss of COL11A1 homolog expression in zebrafish (col11a1a) and mouse (Col11a1) cells 
leads to severe chondrodysplasia that affects cells behavior and tissue shape. Treatment 
enhancing COL11A1 protein production in humans may be useful in inhibiting excessive 
mineralization. On the other hand, inhibition of COL11A1 protein production could be 
useful for tissue engineers and researchers developing treatments to accelerate the 
mineralization of cartilage during fracture healing in patients.
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CHAPTER ONE: INTRODUCTION 
The Extracellular Matrix 
Morphogenesis is the process of forming the tissue shape during development. 
Many factors influence the morphogenesis including autonomous cell behavior, cell-cell 
interactions, soluble growth factors and the extracellular matrix (ECM). Conceivably, 
some of the most fascinating influences come directly from the ECM. The ECM is a 
dynamic network of diverse molecules secreted during tissue development and 
morphogenesis (Rozario and DeSimone 2010). Molecules found outside the cell and that 
have formed an insoluble network through crosslinking interactions are typically 
considered the ECM. The molecules contributing to these molecular networks remain 
close to the site at which they were secreted by the cell, creating a conserved and 
predictable environment for the cell during the stages of development and 
morphogenesis. 
Collagens, proteoglycans and glycosaminoglycans, and the non-collagenous 
glycoproteins are major molecules that contribute to the composition of the ECM (Hynes 
2009). Collagens are the most abundant protein in the vertebrate body with at least 28 
different collagen types identified (Shoulders and Raines 2009). The collagen alpha 
chains form trimeric molecules that assemble and form triple helical regions. Collagens 
are primarily considered structural molecules, providing strength and support for the 
tissue (Gordon and Hahn 2010). Glycosaminoglycans (GAGs) are linear and unbranched 
polymers of the disaccharides hexosamine and uronic acid. GAGs are classified by the 
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composition of their carboxyl, hydroxy and sulfate groups (i.e. chondroitin, dermatan, 
keratan and heparan sulfates). GAGs, excluding hyaluronan (HA), are covalently linked 
to core proteins to assemble the proteoglycans. On the other hand, HA links 
proteoglycans into an essential network critical for establishing the pericellular matrix 
(Evanko et al. 2007). HA can induce cell behavior through interactions with the cell 
surface receptor CD44 and provides one example of ECM induced cell signaling (Toole 
2004). The non-collagenous glycoproteins include fibronectin, tenascin, and laminin all 
of which share common structural motifs such as Arg-Gly-Asp (RGD) sequences. The 
RGD sequences are essential for integrin mediated binding, and therefore provide a 
means for cell-matrix interactions (Shattil et al. 2010) 
Both the individual molecules as well as the architecture of the ECM mediate cell 
behavior in diverse and complex ways. Cell surface receptors interact with individual 
structural motifs found within large extracellular molecules such as the collagens 
(Discher, Mooney, and Zandstra 2009). On the other hand, the matrix environment can 
both limit or facilitate the interaction of smaller morphogens with the appropriate 
receptors and co-receptors (Fuerer, Habib, and Nusse  2010). Of course, these 
interactions never occur in isolation, and the cell must interpret multiple matrix-cell as 
well as cell-cell interactions at a given time and respond favorably to generate and 
maintain a normal tissue. Additionally, the cell response itself can cue changes in the 
ECM that the cell must also respond to, creating a dynamic environment. 
Although the molecules of the matrix can be very stable and long lived, changes 
to the ECM composition occur to facilitate tissue development and morphogenesis 
(Mouw, Ou, and Weaver 2014). These changes are mediated through the synthesis and 
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secretion of additional molecules and through the active degradation and replacement of 
the existing molecules. For example, the secretion of proteases such as matrix 
metalloproteinase (MMP) and a disintegrin and metalloprotease (ADAM) degrade and 
disrupt the stable molecular networks (Lu et al. 2011). Changes in gene expression 
altering protein translation and secretion, contribute to an evolving ECM and cellular 
behavior. 
Cell migration is a fundamental process of development that requires ECM 
interactions. Focal adhesions are integrin based complexes that connect the cell 
cytoskeleton with extracellular substrates such as collagens and fibronectin, to generate 
traction forces and create cell locomotion (Cukierman et al. 2001). Differential 
compositions of integrin subunits and binding motifs provide directional cues for cellular 
migration. Additionally, diffusible factors such as morphogens that bind surface receptors 
can direct cell migration. Once cells reach the site of the future tissue, adhesion and 
differentiation processes can proceed. 
Loosely associated vertebrate cells can form tight associations with each other 
and the extracellular matrix through cell adhesion molecules (CAMs). Cadherins are 
calcium dependent cell-cell adhesion molecules that hold cells together during vertebrate 
development, although they are also expressed in invertebrates. Cadherins are typically 
single-pass transmembrane glycoproteins that form dimers and connect the actin 
cytoskeleton of neighboring cells. The expression of cadherins are dynamic and can be 
considered cyclic during embryonic development to facilitate changes in cell location, 
providing another morphogenic mechanism (Takeichi 1991). For example, Neural 
cadherin (N-cadherin or Cdh2) expression can be detected in the developing neural tube 
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before it is down regulated as neural crest cell migration begins (Taneyhill and 
Schiffmacher 2017). Then, at new sites of tissue development, where cell adhesion is 
required to facilitate differentiation and patterning, such as in the developing brain or 
cartilage, N-cadherin expression reemerges. 
Cell fate decisions and differentiation during development is also influenced by 
the composition of the ECM, although ultimately controlled by gene expression patterns 
driven by transcription factors. The contribution of the ECM is complicated by the 
multitude of molecules presented to the cell and apparent compensatory mechanisms that 
may mask the direct contribution of individual molecules. For example, studies 
disrupting the expression of matrix molecules through loss of function experiments often 
cause multiple defects or a spectrum of severity that are difficult to interpret as a direct 
effect. Additionally, disruption of the ECM can have no effect on cell differentiation, but 
still cause severe disorganization of the cells within the tissue. The cellular 
disorganization itself may expose cells to cues that alter cell fate and differentiation 
pathways disrupting the overall tissue pattern. 
Tissue patterning during development is mediated through well conserved 
secreted signaling molecules such as the transforming growth factor (TGF), fibroblast 
growth factor (FGF), Wingless/integrated (Wnt) and hedgehog (Hh) families, in 
combination with the direct cell-cell signaling induced through Notch (Clevers 2006, 
Goldring, Tsuchimochi, and Ijiri 2006, Swartz et al. 2012, Melrose et al. 2016). The 
ECM can indirectly influence the availability of these molecules to the required cell 
surface receptor. For example, matrix molecules may bind and sequester soluble 
signaling molecules, preventing the ligand-receptor interactions from occurring or 
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attenuating the interaction. Alternatively, the receptors themselves may be masked from 
the ligand through direct or indirect ECM interactions. Additionally, the matrix 
composition alters the charge density and volume of the fluid which mediate 
concentration gradients and rates of diffusion. These mechanisms indirectly influence cell 
behavior through modulating the availability of the soluble morphogen but should be 
considered attributes of the ECM. 
Endochondral Ossification 
Endochondral ossification is a tightly regulated, multistep process of skeletal 
formation. Most of the bones in the vertebrate skeleton, such as the vertebrae, ribs and 
long bones, form through the process of endochondral ossification. Unlike 
intramembranous ossification, endochondral ossification must be preceded by the 
formation of cartilage anlagen that serve as templates. The steps involved in 
endochondral ossification are mesenchymal condensation, chondrogenic differentiation 
of mesenchymal cells and cartilage formation, primary ossification and secondary 
ossification (Figure 1) (Kozhemyakina, Lassar, and Zelzer 2015). 
Initially, mesenchymal cells migrate to the site of the future bone and commit to 
the chondrogenic lineage in preparation of chondrogenesis, the formation of cartilage. 
The cells contributing to the vertebrate skeleton arise from multiple lineages, depending 
on the skeletal element. For example, cranial neural crest cells arise from the anterior-
dorsal aspect of the closing neural tube, delaminate and migrate in a distinct stream to 
populate the ventral pharyngeal arches, which give rise to the craniofacial skeleton. On 
the other hand, cells contributing to the skull, middle ear, ribs and vertebrae of the axial 
skeleton arise from somites, or paraxial mesoderm, while the cells of the appendicular 
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skeleton arise from lateral plate mesoderm (Chai et al. 2000, Kague et al. 2012, 
Berendsen and Olsen 2015). Regardless of the initial source of the cells, they must 
migrate to the future site of the bone to initiate mesenchymal condensation and 
subsequently, chondrogenesis. 
After successful migration, mesenchymal cells form high density cellular 
condensations and upregulate the expression of versican, tenascin, syndecan, N-CAM 
and N-cadherin. Cells surrounding the condensation form the perichondrium and 
establish the cartilage border. The perichondrium prevents additional mesenchymal cells 
from being recruited to the condensation. Proliferative cells in the center of the 
condensation will differentiate into cartilage forming chondrocytes (Hall and Miyake 
2000). 
Chondrocytes secrete a cartilage matrix that contains collagens, proteoglycans, 
hyaluronan and noncollagenous glycoproteins. Collagens type II, IX, and XI are highly 
expressed in the developing cartilage, as are sulfated proteoglycans. As chondrogenesis 
proceeds, chondrocytes mature and develop spatially recognizable zones with 
phenotypically unique characteristics that define the growth plate (Goldring et al. 2006, 
Berendsen and Olsen 2015) (Figure 2). Chondrocyte hypertrophy and matrix 
mineralization occurs as cells cease proliferation, increase in cell volume and 
differentiate into hypertrophic chondrocytes. These cells express collagen type X 
followed by increased matrix metalloproteinase-13 (MMP13) and alkaline phosphatase 
(Kozhemyakina et al. 2015). Neighboring perichondrial mesenchymal cells differentiate 
and form osteoblasts of the bone collar. Vascular invasion and ossification occurs in the 
final stage as hypertrophic chondrocytes undergo apoptosis. The vascularization is 
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necessary to recruit chondroclast that resorb the ECM around the hypertrophic cells and 
osteoblasts that secrete new bone and thus creating the primary ossification center of the 
bone. 
The growth plate is a specialized tissue that enables the longitudinal elongation of 
the long bones and persists until the end of adolescence (Melrose et al. 2016). 
Chondrocytes in the growth plate undergo spatially organized differentiation and 
maturation processes. The differentiation stage is organized by the transcriptional activity 
regulated by tissue specific growth factors. Chondrocytes in the resting zone are 
dispersed within the extracellular matrix and are isolated from the ossification front. 
These cells are a pool of cells that contribute to the proliferative zone chondrocytes. 
Chondrocytes in the proliferative zone of the growth plate are flat and orientated with the 
long axis perpendicular to the plane of longitudinal growth. Clonal expansion of the cells 
generates a columnar structure with a stack like appearance (Figure 2). The cartilage 
producing cells in the upper proliferative zone synthesize and secrete abundant collagen 
type II and aggrecan. Chondrocytes in the prehypertrophic zone begin to increase in size 
and express Indian hedgehog (Ihh) and parathyroid hormone-related peptide receptors 
(Vortkamp et al. 1996). Cells in the hypertrophic zone are non-proliferative and secrete 
collagen type X instead of collagen type II. Interestingly, the fate of the hypertrophic 
chondrocyte is divided by at least potential outlooks. The first is that hypertrophic cells 
die by apoptosis and are subsequently replaced by osteoblast, and the second suggesting 
hypertrophic chondrocytes transdifferentiate directly into osteoblast (Hill et al. 2005, 
Yang et al. 2014). 
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Regulation of Chondrogenesis 
The Sry-related high-mobilty group box (Sox) transcription factor, SOX9, has 
been identified as the master regulator for chondrogenic commitment and differentiation 
of mesenchymal cells (de Crombrugghe, Lefebvre, and Nakashima 2001, Lefebvre et al. 
2007). Sox9 transcripts are expressed in both chondroprogenitor cells and differentiated 
chondrocytes and declines in hypertrophic chondrocytes (Lefebvre and Dvir-Ginzberg 
2017). Sox9 binds the Col2a1, Col11a2 and aggrecan promoters, making it essential for 
cartilage formation (Bell et al. 1997, Deng, Huang, and Yuan 2016). Interestingly, loss of 
SOX9 before mesenchymal condensation prevented the aggregation of mesenchymal 
cells and the loss of subsequent skeletal formation. On the other hand, deletion of SOX9 
after mesenchymal condensation caused severe chondrodysplasia with decreased 
proliferation and maturation. In addition to the effects on proliferation, loss of SOX9 
causes disorganization of cells in the growth plate. The expression of SOX9 is required to 
prevent proliferating chondrocytes from transitioning into hypertrophic chondrocytes 
(Akiyama et al. 2002). Furthermore, overexpression of SOX9 in chondrocytes decreased 
cell proliferation through interactions with the canonical Wnt signaling pathway 
(Akiyama 2004, Topol et al. 2009). 
The Wnt signaling pathway plays conserved roles in regulating fundamental cell 
behavior during tissue development and morphogenesis in multiple tissue, including 
skeletal tissues (Clevers 2006). During skeletal development, Wnt influences the cell fate 
decisions of mesenchymal stem cells by directing them toward either the chondrocyte or 
osteocyte lineage (Day et al. 2005, Hill et al. 2005, Reinhold et al. 2006)  High β-catenin 
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levels inhibit Sox9 expression and activity while promoting runt-related transcription 
factor-2 (Runx2) expression, therefore promoting differentiation toward the osteoblast 
lineage. Additionally, activation of T-cell specific transcription factor/lymphoid 
enhancer-binding factor (TCF/LEF) in chondrocytes accelerates hypertrophic 
differentiation and stimulates ectopic mineralization (Kitagaki et al. 2003). On the other 
hand, low Wnt/β-catenin signaling enhances Sox9 expression and promotes the 
chondrocyte fate. Therefore, the balance of Wnt/β-catenin is an important molecular 
switch between chondrocyte and osteoblast fate choice in mesenchymal cells contributing 
to skeletal development. 
Wnt molecules can act through at least three unique signaling pathways leading to 
distinct cellular responses: canonical Wnt signaling, noncanonical planar cell polarity, 
and Wnt/calcium dependent pathways. Canonical pathways refer to the involvement of β-
catenin in the signal transduction. In the canonical Wnt signaling pathway, the absence of 
Wnt binding to the seven pass transmembrane surface receptor frizzled, promotes β-
catenin phosphorylation at the amino terminal domain by glycogen synthase kinase 
(GSK) 3β and casein kinase 1α (CK1α) in a complex with the scaffolding protein axin 
and adenomatous polyposis coli (APC). This phosphorylation event on β-catenin targets 
it for subsequent ubiquitination and proteasome mediated degradation (Aberle et al. 
1997). On the other hand, binding of Wnt to the frizzled receptor and co-receptor LDL 
related proteins (LRP) 5/6, leads to phosphorylation of GSK3β and thereby uniquely 
inhibiting GSK3β’s kinase activity, and stabilizing β-catenin levels in the cytoplasm. 
Stable β-catenin accumulates and translocates to the nucleus where it interacts with T-cell 
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specific transcription factor/lymphoid enhancer-binding factor (TCF/LEF) to drive Wnt 
target gene transcription. 
GSK3β is a serine/threonine kinase with multiple substrates including β-catenin 
(Doble and Woodgett 2003, Saegusa et al. 2009, Umschweif et al. 2013). Uniquely, 
GSK3β is an active kinase under normal conditions and is inhibited when phosphorylated 
at serine-9. Phosphorylation is mediated by several upstream kinases including 
phosphoinositide 3-kinase (PI3K)/AKT, cyclic AMP-dependent protein kinase (PKA) 
and protein kinase C (PKC). As mentioned above, GSK3β mediated phosphorylation of 
β-catenin leads to the ubiquitination and proteasome-mediated degradation, therefore 
decreasing the activity of TCF/LEF transcription factors (Clevers 2006). Therefore, 
GSK3β is an important mediator of chondrocyte behavior and cell fate decisions through 
the regulation of β-catenin degradation and stabilization. 
Collagen α1(XI) 
Collagen type XI is a heterotrimeric protein containing three unique chains, 
α1(XI), α2(XI) and α3(XI) (Mendler et al. 1989, Fernandes et al. 2007). The collagen 
α1(XI) chain is translated as a procollagen alpha chain that will undergo future 
modifications through proteolytic cleavage of the amino and carboxyl terminal ends. The 
rate of proteolytic cleavage at the amino terminal domain is influenced by the variable 
region located between the amino terminal domain and the major triple helix (Medeck et 
al. 2003, Oxford et al. 2004). 
The COL11A1 gene contains 67 exons in which exons 6 through 9 (also referred 
to as exons 6a through 8) are subject to alternative splicing (Davies et al. 1998). 
Alternative splicing of COL11A1 mRNA leads to complex combinations of exons 6A, 
11 
 
 
6B, 7 and 8 which give rise to variants of the variable region of the collagen α1(XI) 
protein. Exons 2-5 are expressed in all isoforms and code for the conserved amino 
propeptide. The variable region is included in the amino terminal domain but is not part 
of the proteolytically cleaved amino propeptide. Therefore, the variable region is retained 
in the mature collagen fibril and contributes to diverse isoforms of the collagen type 
α1(XI) chain. The expression of the isoforms is regulated during embryonic development 
and are tissue specific (Davies et al. 1998, Morris et al. 2000). Furthermore, the tissue 
specific expression of collagen type α1(XI) chain isoforms is temporally and spatially 
controlled by cis-acting elements (Chen et al. 2001). 
Collagen type XI is a minor fibrillar collagen expressed in multiple tissues 
including brain, placenta, skeletal muscle, heart, lung, the vitreous bone and cartilage 
(Yoshioka et al. 1995). Collagen type α1(XI) chain is first detected during embryonic 
development in the developing limb and craniofacial cartilage. Additionally accumulating 
evidence has asserted that collagen type α1(XI) chain is a cancer biomarker (Bowen et al. 
2008, García-Pravia et al. 2013, Wu et al. 2015). The tissue distribution has been 
investigated and confirmed in mouse, rat, chick and most recently, zebrafish models (Li 
1995, Yoshioka et al. 1995, Fang et al. 2010). 
The amino terminal domain of collagen α1(XI) chain remains exposed on the 
surface of the fibril for an extended amount of time (Morris and Bachinger 1987). The 
rate at which the amino propeptide is cleaved is influenced or potentially controlled, by 
the isoform present, which is dictated by the variable region primary sequence (Medeck 
et al. 2003, Oxford et al. 2004). The diameter of mature collagen fibrils in cartilage has 
been linked to collagen type XI expression. The amino terminal domain acts to sterically 
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hinder the additional collagen fibrils in the cartilage because the amino terminal domain 
remains extended at the collagen surface (Gregory et al. 2000, Holmes and Kadler 2006). 
The surface location of collagen α1 (XI) amino terminal domain enables the possibility 
for multiple interactions. Proteomic analysis has identified multiple molecules that show 
an affinity for the amino terminal domain. Several collagens (II, IX, XI, XII and XIV), 
proteoglycans biglycan, perlecan, chondroadherin, fibromodulin, epiphycan, 
thrombospondin 1 and 5, and matrilin 1 and 3, were found to interact with the amino 
terminal domain either directly or indirectly (Oxford et al. 2004). 
Mutations in human COL11A1 gene are the cause of Fibrochondrogenesis a 
neonatally lethal chondrodysplasia (Lazzaroni-Fossati 1978, Li 1995, Tompson et al. 
2010). Heterozygous mutations in COL11A1 cause milder forms of chondrodysplasia, 
Stickler’s syndrome type II and Marshall’s syndrome (Vijzelaar et al. 2013, Acke et al. 
2014). COL11A1 associated chondrodysplasia present with long bone and rib shortening 
with flared metaphysis or cupping, vertebral malformation, flattened midface, reduced 
jaw protrusion and sensorineural defects affecting hearing and vision (Whitley et al. 
1984, Akawi, Al-Gazali, and Ali 2012, Hufnagel et al. 2014). 
The chondrodystrophic mouse (cho) demonstrates the importance of Col11a1 
expression in development. The autosomal recessive chondrodysplasia is caused by a 
mutation generating a reading frame shift in the Col11a1 gene that produces a premature 
stop codon (Li 1995). The collagen diameter in the cho mouse is abnormally thick, 
highlighting the ultrastructural influence of collagen type XI on fibril diameter 
(Fernandes et al. 2007). Recent analysis of the cho mouse demonstrated the importance 
of Col11a1 in regulating mineralization of the bone collar and trabecular bone (Hafez et 
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al. 2015). These developmental defects irrefutably demonstrate the necessity of 
COL11A1 expression in skeletal development. 
 
 
 
Figure 1.1. Schematic of cartilage development and endochondral ossification. 
Source: (Usami et al. 2016) The process of endochondral ossification requires multiple 
steps to successfully develop the cartilage and bone. (a) Mesenchymal cells first form 
a condensation at the future site of the cartilage. The cells of the condensation 
contribute to cells of the chondrocyte and osteoblast lineage. Chondrocyte 
differentiation and matrix production occurs in the mesenchymal condensation. (b) 
The cells of the condensation continue to grow, differentiation and organize the 
cartilage template, creating the growth plate. Perichondral cells border the cartilage 
template and prevent the addition of new mesenchymal cells. (c) Cells in the center 
undergo hypertrophy and create the primary ossification center that is occupied by 
microvessels. (d) Vessels invade at the epiphyses, and generate a secondary 
ossification center that contains osteoblast. (e) The growth plate continues to advance 
and promote longitudinal growth. The articular cartilage is formed at the superficial 
surface providing resilience in load-bearing situations and a smooth surface for the 
joint. 
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Figure 1.2. Organization of the growth plate and articular cartilage Source:(Usami 
et al. 2016). (A) The growth plate contains distinct zones with morphological 
differences in each: The resting zone, proliferating zone, prehypertrophic zone, and 
hypertrophic zone. (B) The articular cartilage also contains distinct zones: Superficial 
layer, mid layer, deep layer, calcified layer. 
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Figure 1.3. Canonical Wnt signaling pathway. Source: (Clevers 2006). In the 
absence of the Wnt ligand, CK1 and GSK3 phosphorylate β-catenin. Phosphorylated 
β-catenin is recognized by β-TrCP of the E3 ubiquitin ligase complex, ubiquitinated, 
and degraded by the proteasome. Therefore, in the absence of Wnt ligand, 
cytoplasmic β-catenin does not accumulate or enter the nucleus to activate Wnt target 
genes. In the presence of Wnt ligand, the Frizzled/ LRP complex activates the 
canonical signaling pathway. Axin is recruited to the membrane and β-catenin 
escapes phosphorylation and subsequent ubiquitination and degradation. Therefore, 
β-catenin accumulates in the cytoplasm and translocates to the nucleus. In the 
nucleus, β-catenin interacts with TCF/LEF and promotes the expression of Wnt 
target genes. 
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CHAPTER TWO: ZEBRAFISH COL11A1A REGULATES CRANIOFACIAL 
MORPHOGENESIS DURING DEVELOPMENT 
Abstract 
Expression of the col11a1a gene is essential for normal skeletal development in 
both cartilage and bone. Although col11a1a loss of function mutations cause abnormal 
growth plate organization, the effect on craniofacial development has not been well 
studied. To further understand the effect of col11a1a gene function in craniofacial 
development, we analyzed the developing craniofacial skeleton in zebrafish using gene 
knockdown by injection of antisense morpholino oligonucleotide (AMO). We 
demonstrate that col11a1a knockdown impairs organization of the craniofacial cartilage 
and bone forming cells in and adjacent to the Meckel’s cartilage. These results are 
consistent with reported cell behavior in the growth plate and suggest a conserved role for 
col11a1a expression in growth plate and jaw. 
Introduction 
The craniofacial skeleton is derived from cranial neural crest cells (CNCC) that 
migrate into the pharyngeal arches and establish a cartilage anlagen (Kimmel et al. 1998, 
Kague et al. 2012, Berendsen and Olsen 2015). The cranial neural crest cells of the seven 
pharyngeal arches occupy the appropriate segmented arch through predetermined 
migratory streams during craniofacial development (Schilling and Kimmel 1994). The 
first of seven pharyngeal arches give rise to the Meckel’s cartilage which functions as the 
cartilage template of the mandible, or lower jaw (Mork and Crump 2015). Ossification of 
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the mandible occurs through a combination of intramembranous ossification at the 
mediolateral dentary and endochondral ossification at the distal-most cartilage (Eames et 
al. 2013). 
During development, most of the skeleton is composed of cartilage, a firm yet 
flexible connective tissue composed primarily of chondrocytes embedded in a collagen 
and proteoglycan rich matrix. Collagens are a large family of extracellular molecules of 
at least 28 members found mostly in connective tissues (Carter and Raggio 2009, Ricard-
Blum 2011). The functions of collagens are diverse and have been linked to cell 
adhesion, migration, structure and cell signaling during skeletal morphogenesis (Kadler et 
al. 2007). 
The collagen type XI alpha 1 gene, COL11A1, is expressed by chondrocytes in 
the developing fetal cartilage, the growth plate, and articular cartilage. The translated 
protein is incorporated into collagen type XI fibrils and primarily localized to thin fibrils 
of the pericellular matrix of chondrocytes. Collagen type XI heterotrimeric molecules are 
composed of two unique alpha chains, α1(XI), α2(XI), as well as the α3(XI) chain which 
is  identical to collagen α1(II)B (Poole, Flint, and Beaumont 1987, Eyre 2002). 
Autosomal recessive null mutations in COL11A1 cause the lethal chondrodysplasia, 
Fibrochondrogenesis in humans (Tompson et al. 2010). Mutations that reduce or modify 
COL11A1 gene expression cause milder forms of chondrodysplasia in Stickler’s and 
Marshall’s syndrome (Vijzelaar et al. 2013, Acke et al. 2014). Fibrochondrogenesis is 
clinically characterized by long bone and rib shortening with flared metaphysis or 
cupping, vertebral malformation, flattened midface, reduced jaw protrusion and 
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sensorineural defects affecting hearing and vision (Whitley et al. 1984, Akawi, Al-Gazali, 
and Ali 2012, Hufnagel et al. 2014). 
Ultrastructural and biochemical analysis of collagen type XI alpha one chain  
molecules have provided valuable information regarding structure, location and binding 
interactions (Warner et al. 2006, McDougal et al. 2011, Brown et al. 2011, Ryan et al. 
2015). In addition, clinical samples and animal models have indicated a clear link 
between chondrodysplasia, chain misassembly and COL11A1 gene defects (Fernandes et 
al. 2007). This study seeks to elucidate the impact that zebrafish col11a1a gene defects 
have on tissue morphogenesis and cell organization during skeletal development. 
Evidence that COL11A1 gene defects disrupt the growth plate and long bone 
development in human patients led us to hypothesize that zebrafish col11a1a is essential 
for craniofacial development. Based on this hypothesis, we predict that col11a1a gene 
defects will disrupt chondrocyte organization and subsequent mineralization in 
craniofacial development. 
Methods 
Fish Care and Transgenic Lines 
Vertebrate animal use was approved by the Institutional Animal Care and Use 
Committee (IACUC Protocol 006-AC15-011)). Zebrafish embryos were obtained from 
ZIRC (Eugene, OR). The following lines were used in these studies; AB, Tg(sp7:EGFP) 
(DeLaurier et al. 2010) and Tg(Fli1a:EGFP) (Lawson and Weinstein 2002). 
Morpholino Injections 
Gene-specific and standard control antisense morpholino oligonucleotides (AMO) 
were purchased from Genetools, LLC (Philomath, OR). The col11a1a morpholino 
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targeted the translational start site with the following sequence:  5’-
GGGACCACCTTGGCCTCTCCATGGT-3’. Morpholinos were diluted in water and 
0.05% phenol red. The morpholinos were injected at a volume of 2 nL and at a 
concentration of 3 ng/nL. 
Cartilage and Bone Staining 
Five days post fertilization (dpf) zebrafish embryos were fixed overnight with 4% 
paraformaldehyde in phosphate buffered saline (PBS). The samples were washed with 
PBS with 0.1% Tween-20 (PBT) then dehydrated through a 30:50:90% series of ethanol 
followed by overnight incubation in Alcian blue solution of 0.1mg/mL in 75:25% 
ethanol:acetic acid overnight with rocking. Samples were rehydrated through 70:50:30% 
ethanol series and bleached in 1% hydrogen peroxide and monitored until the eyes were 
clear (2-3 hours). 
For vital imaging of calcification, live zebrafish were incubated in 30 mL of the 
zebrafish housing system water with 200 µL of 0.5% Alizarin Red (final concentration 
0.003%) for 3 hour. Fish were subsequently rinsed in zebrafish housing system water 
prior to imaging. 
Imaging 
Transgenic zebrafish were anesthetized in 0.016% tricaine methanesulfonate 
(MS-222) in system water prior to mounting in 0.6% (w/v) low melting point agarose 
containing MS-222. Confocal imaging was performed using a Zeiss LSM 510 Meta 
inverted laser scanning microscope. Alizarin Red vital stained images were collected by 
excitation between 530-560 nm and by monitoring emission at 580 nm. GFP transgene-
expressing zebrafish images were generated by excitation at 488 and monitoring emission 
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at 509 nm. Wide field fluorescence microscopy was also performed using the EVOS Fl 
imaging system (ThermoFisher Scientific). Alcian blue stained zebrafish were mounted 
in glycerol and imaged using the Olympus BX53 light microscope. 
Results 
Knockdown of Col11a1a Leads To Skeletal Deformities In Zebrafish 
Fibrochondrogenesis is clinically distinguished by wide long-bone metaphyses, 
abnormally pear-shaped vertebral bodies, flattened facial appearance, micrognathia and 
abnormal curvature of the spine. In addition, ultrastructural changes in the growth plate 
cartilage and chondrocyte dysplasia are observed at the microscopic level (Lazzaroni-
Fossati 1978, Whitley et al. 1984, Tompson et al. 2010). We compared morphant and 
wild type zebrafish at 5 dpf. By this time most of the cartilage elements have developed 
and can be stained with Alcian blue to detect the cartilaginous ventral pharyngeal 
skeleton. Col11a1a antisense morpholino oligonucleotide (AMO) induced a 
chondrodysplasia that recapitulates Fibrochondrogenesis and morphants were 
distinguishable from stage-matched controls (Figure 1). The body axis of the morphants 
were curved ventrally, the midface had a flattened appearance and the jaw size was 
reduced. In addition to the skeletal defects, heart edema was observed (Figure 1B). 
Otoliths were abnormal and fused when compared to the controls (Figure 1D). Staining 
GAGs of the cartilage with Alcian blue showed the knockdown of col11a1a caused the 
development of cartilage derived from the pharyngeal arches to be deformed (Figure 1E). 
Specifically, the Meckel’s cartilage of the control zebrafish was completely formed and 
extended to enable lower jaw articulation, indicating appropriate development had 
occurred. In contrast, Alcian blue staining of the morphants revealed that the Meckel’s 
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cartilage was smaller compared to zebrafish injected with the control AMO and 
compared at stage matched times. Further examination of the Meckel’s cartilage showed 
that not only does it fail to protrude, but the overall shape is altered. The lower jaw 
normally extends anteriorly and forms a single stack of cells by 5 dpf in normal zebrafish 
development (Piotrowski et al. 1996, Schilling et al. 1996). Inhibiting col11a1a 
expression by injection of AMO disrupted morphogenesis of the developing craniofacial 
skeleton, causing the eyes to appear that they are bulging. Also, the zebrafish otoliths 
became abnormally positioned in the otic vesicle as a condition of the severe dysplasia. 
Additionally, the 2nd arch failed to form anteriorly pointing segments at the midline of the 
zebrafish. The remaining posterior arches, ceratobranchial 1-5, were weakly stained and 
lacked the proper structure. 
Cranial Neural Crest Derived Cells Form Segmented Pharyngeal Arches with 
Abnormal Shape 
The cells of the pharyngeal arches were visualized by laser scanning confocal 
microscopy using the transgenic Fli1a:EGFP reporter (Figure 2). Fli1a is expressed in 
cranial neural crest derived mesenchymal cells of the developing cartilage as well as the 
aortic arches and endothelial cells of the vasculature. Enhanced green fluorescence 
protein (EGFP) expression in the neural crest derived cells of the developing pharyngeal 
skeletal can be detected until at least 7dpf (Lawson and Weinstein 2002). The EGFP was 
imaged 72-hours post fertilization to determine if the cells of the pharyngeal arches could 
organize in a manner sufficient to establish the cartilage template of the future 
craniofacial skeleton. We identified the neural crest derived cell pattern in the morphants 
and compared it to the control embryos (Figure 2). We predicted that the cells of the 
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pharyngeal arches would form condensations but not migrate and organize into ordered 
columns representing the normal cellular organization of the developing cartilage. 
Consistent with this prediction, the neural crest derived cells formed abnormally shaped 
pharyngeal arches in the morphants. We determined that the CNCCs occupied segmented 
pharyngeal arches, but subsequent patterning consistent with cartilage development failed 
to occur. Notably, the 1st and 2nd arches were closer to each other and neither arch 
extended anteriorly as seen in normal development (Figure 2B). Each pharyngeal arch 
was present and segmented from each other, and cell populations that could potentially 
contribute to cartilage development were present. The overall pattern at this stage was not 
consistent with normal cartilage development and patterning. 
The lateral view of the normal zebrafish was used to visualize the extension of the 
Meckel’s cartilage at this stage of development. Meckel’s cartilage supports lower jaw 
formation by forming a template for mineralization. The morphant jaw failed to extend 
anteriorly to the extent that the control jaw, and cells of the palatoquadrate did not 
organize into stacked cells (Figure 2B). The result of these two events resulted in both a 
smaller and wider Meckel’s cartilage, and formed kinks in the palatoquadrate where cell 
alignment normally contributes to generating a protruding structure. A ventral view of the 
ceratobranchial arches showed that they were smaller and cellular organization was 
distinguishable from the control zebrafish. The ceratobranchial arches did not extend 
anteriorly, but instead pointed toward the midline (Figure 2D). 
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Cells in the Meckel’s Cartilage Fail To Converge And Extend In Col11a1 
Morphants 
We analyzed the cell organization of the Meckel’s cartilage in 5 dpf zebrafish to 
determine if the observed craniofacial defects in col11a1a chondrodystrophies is 
correlated with unaligned cells. Additionally, we analyzed the effect on mineralization of 
the cartilage template. At this stage in development, the anterior region of the jaw 
cartilage should be fully developed. We observed that the organization of the cells in the 
morphant was distinct. The cells of the Meckel’s cartilage form a single file column 
under normal conditions (Figure 3A). We observed both cartilage forming cells, which 
form the single column, and perichondral bone forming cells lining the Meckel’s 
cartilage. The cartilage lining cells produced a mineralized matrix that was detectable 
with Alizarin Red in controls (Figure 3B and C). Mineralization along the normal jaw is 
intramembranous and contributes to the zebrafish dentary and maxilla. In contrast, cells 
in the morphant failed to organize into a single stack and the two-bilateral rod-like arches 
did not extend anteriorly (Figure 3D). Additionally, mineralization of the dentary was not 
observed, but instead mineralization of the cartilage where the two rods of the Meckel’s 
cartilage meet at the anterior-most region was detected (Figure 3 E and F). This is a site 
presumed to mineralize through endochondral ossification (Eames et al. 2012). We found 
that the cells contributing to the Meckel’s cartilage failed to form single file columns and 
that mineralization pattern was altered. 
Bone Forming Cells Form Condensations at the Morphant Meckel’s Cartilage 
Sp7/osterix expression in bone forming cells has been reported in mice and 
zebrafish models (Nakashima et al. 2002, DeLaurier et al. 2010). To determine if the 
31 
 
 
bone forming cells lining the Meckel’s cartilage were displaced by the abnormal template 
shape, we tracked the location of the EGFP positive cells in the transgenic sp7:EGFP 
zebrafish. We predicted that the osteocytes would not be able to organize and form a 
detectable mineralized jaw. At 5 dpf, the Meckel’s cartilage defect in the morphant jaw 
was detectable in the transgenic morphants while the control zebrafish had a protruding 
jaw and normal midface (Figure 4A and B). Sp7:EGFP positive cells were detected by 
fluorescence microscopy adjacent to the developing Meckel’s cartilage. The sp7:EGFP 
positive cells in the control zebrafish were detected lining the cartilage and the 
mineralization pattern followed the expression pattern of sp7:EGFP positive cells (Figure 
4A). In the developing morphant jaw, sp7:EGFP cells were located in the mediolateral 
cartilage rods, but the cells did not line the cartilage as did the perichondral cells of the 
control. Instead, the cells formed small condensations adjacent to the cartilage and did 
not produced detectable mineralization at this time point (Figure 4D). Although 
sp7:EGFP cells were not detected at the distal tip of the cartilage where the cartilage rods 
meet, mineralization was detectable, suggesting accelerated endochondral ossification, 
potentially by increased calcifying chondrocytes. 
Discussion 
Collagen expression is linked to a large and diverse group of skeletal 
developmental diseases (Jobling et al. 2014, Deng, Huang, and Yuan 2016). 
Endochondral bone formation begins when mesenchymal cell condensations form and 
initiate production of the cartilage template. The cartilage increases in size and develops 
shape and structure through cell maturation and extracellular matrix production 
(Kronenberg 2003). While col11a1a has been linked to chondrodystrophies, the influence 
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of Col11a1a protein on cell behavior and organization remains unclear. Determining how 
a Col11a1a-deficient matrix may impact cartilage and bone morphogenesis through the 
spatial organization and behavior of cells is an important step in understanding skeletal 
development as well as degenerative diseases. 
In this study, we analyzed the spatial arrangement of cells in zebrafish during 
craniofacial development after col11a1a knockdown by AMO injection. Through 
fluorescence microscopy and tissue staining, we determined that col11a1a deficiency 
disrupts the morphogenesis of pharyngeal arch derived cartilage and bone by preventing 
the normal arrangement of cells. 
Collagen is the major component of the cartilage extracellular matrix secreted by 
chondrocytes. Collagen type XI plays a structural role in the cartilage through many 
interaction including nucleating and limiting the diameter of collagen type II fibrils and 
interacting with non-collagenous molecules (Wu and Eyre 1995, Brown et al. 2011). A 
previous study demonstrated severe changes to the extracellular matrix and collagen 
network when col11a1a AMO were injected into zebrafish (Baas et al. 2009). Col11a1 
mutations in the chondrodysplasia (cho) mouse also showed disorder chondrocytes and 
collagen fibers in the growth plate (Li et al. 1995, Fernandes et al. 2007). Micro-
computed tomography (µ-CT) analysis of the same mouse model revealed alterations in 
the mineralization of the developing long bones, ribs, vertebrae and skull (Hafez et al. 
2015). These reports are consistent with our findings indicating col11a1a is required for 
normal endochondral ossification in zebrafish. 
The first pharyngeal arch contributes to the Meckel’s cartilage and the bones of 
the inner ear (Schilling and Kimmel 1994, Chai et al. 2000, Kague et al. 2012). In 
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col11a1a morphants, the lower jaw was affected as well as the otoliths of the developing 
ear. Although the otoliths are present the size and location of the otoliths are altered. 
Previous research has identified collagen gene expression, specifically col2a1 and 
col11a1a in the developing zebrafish ear (Fang et al. 2010; Nemoto et al. 2008)  This is 
consistent with reported craniofacial and hearing defects that occur in 
Fibrochondrogenesis as well as Stickler’s syndrome patients (Acke et al. 2012, Akawi et 
al. 2012). 
These data support our conclusion that the cells in the craniofacial skeleton are 
subject to similar mechanisms as the cells of the long bone growth plate and that the 
absence of col11a1a impacts the cellular arrangement and alters mineralization. Based on 
these findings, we propose; 1) the loss of Col11a1a protein prevents cell-matrix 
interactions that permit cell intercalation and; 2) loss of Col11a1a protein prematurely 
promotes cartilage matrix mineralization. Testing these hypotheses and determining the 
molecular mechanisms involved will be the subject of future studies. 
This study was limited to analyzing the overall shape of tissues, arrangement of 
cells that contribute to skeletal morphogenesis and the accumulation of proteoglycans and 
presence of mineralization. No effort was made in the current study to determine the gene 
or protein expression in the cell populations. It is important to note that 
chondrodystrophies linked to COL11A1 present as a spectrum of disorders, such as 
Stickler’s syndrome (Stevenson et al. 2012). Variations in the morphant phenotype and 
lethality were observed and therefore make it challenging to generalize broadly about the 
effect of COL11A1 deficiencies. Because zebrafish col11a1a is expressed in many 
tissues, embryonic lethality could be a possible outcome. 
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Future work will aim to determine the molecular phenotype of the cartilage and 
bone cells. Subsequently, should abnormalities in cell identity be found, the mechanisms 
regulating the cell differentiation and fate should be further investigated. For example, is 
chondrocyte differentiation affected by the absence of co11a1a?  Are the perichondral, 
bone lining cells differentiating properly?  Is hypertrophic differentiation accelerated? 
Does transdifferentiation occur from hypertrophic chondrocytes to osteoblast?  In 
addition to the cell identity, future studies will investigate why the cells fail to organize 
properly. It is possible that planar cell polarity programs are disrupted in col11a1a 
chondrodystrophies. The role of Col11a1a protein in cell signaling pathways that mediate 
planar cell polarity will be investigated in future studies. Integrin-matrix interactions may 
also be inhibited, based on the reported findings of integrin β1 knockdown (Aszodi et al. 
2003). 
In conclusion, loss of col11a1a gene expression not only affects the extracellular 
matrix composition and organization, but also has profound consequences for the spatial 
organization of cells during development of the craniofacial skeleton. Mechanisms 
involving Col11a1a protein during development described here may be conserved in 
other examples of tissue development and degeneration, such as cancer tumor growth 
(Lee, Kim and Kim 2012, Wu et al. 2015) and osteoarthritis (Xu et al. 2003, Rodriguez et 
al. 2004)  Therefore, understanding the impact of col11a1a gene expression on cell 
behavior may contribute to the development of therapies that can target fundamental cell 
mechanisms of growth, differentiation, and homeostasis. 
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Figure 2.1. Col11a1a knockdown causes chondrodysplasia that recapitulates 
Fibrochondrogenesis in zebrafish. Injection of a col11a1a targeting AMO induces 
curvature of the body axis (B) while embryos injected with standard control AMO 
maintain a straight body axis (A). Two otoliths and normal face protrusion are 
present in the control zebrafish (C). In contrast, the morphant zebrafish have fused 
otoliths, heart edema, and an apparent reduction in the face and jaw protrusion (D). 
Alcian blue staining of the pharyngeal arch cartilage shows normal patterning and 
anteriorly facing cartilage (E). Alcian blue staining in the morphant cartilage shows 
perturbed pharyngeal cartilage patterning with a decreased protrusion of the 1st arch 
and posteriorly facing 2nd arch (F). Scale bar in A and B 0.5 mm. Scale bars in C-F 
50 µm 
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Figure 2.2. Cranial neural crest derived cells form segmented pharyngeal arches 
with abnormal shape in the absence of Col11a1a. Fli1a:EGFP positive cells indicated 
that the neural crest derived cells did occupy the pharyngeal arches. After occupying 
the pharyngeal arch however, cells failed to form organized cartilage structures. The 
cells aligned to form an elongated structure in the palatoquadrate (pq) that joins the 
Meckel’s cartilage in the control morphant (A). The pq of the col11a1a morphant did 
not form a straight structure and the Meckel’s did not extend anteriorly (B). The 
ventral view indicated segmentation of each of the developing pharyngeal arches in 
both the control (C) and the morphant (D). Scale bar 50 µm. (m; Meckel’s cartilage, 
pq; palatoquadrate, ch; ceratohyal, cb; ceratobranchial) 
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Figure 2.3. Col11a1a expression is required for Meckel’s cartilage organization, 
elongation and normal mineralization. The Fli1a:EGFP expressing cells in the 
Meckel’s cartilage and bone lining cells formed an organized stack of flat cells that 
extended the Meckel’s cartilage anteriorly (A)  Alizarin Red staining indicated that 
the bone lining cells produced a mineralized rod-like structure bordering the 
Meckel’s cartilage (C, white star) and initiated mineralization at the distal tip (B and 
C)  In contrast, the cells in the morphant were not flat and did not form a stack (D). 
Consequently, the Meckel’s cartilage did not extend anteriorly. Mineralization of the 
bilateral rods in the morphant was not detected (F, white star), although 
mineralization was present at the distal tip (F). Scale bars 20 µm. 
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Figure 2.4. Col11a1a knockdown disrupts the organization of bone forming cells 
lining the Meckel’s cartilage. Ventral view of sp7:EGFP positive cells imaged in 5 dpf 
control zebrafish (A and C) and morphant (B and D). sp7:EGFP expressing cells line 
the cartilage template in control zebrafish (C). sp7:EGFP expressing cells form small 
condensations at the mediolateral cartilage but fail to expand in morphants (D). Scale 
bar 20 µm.   
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Figure 2.5. Model of Meckel’s cartilage development and the cellular organization 
in normal development and in the col11a1a morphant. Cranial neural crest cells form 
initial condensations. During normal development, the cells reorganize and form a 
single file stack of cells that promotes extension anteriorly. In contrast, inhibition of 
col11a1a expression prevents reorganization into stacked cells. Therefore, the 
Meckel’s cartilage does not extend anteriorly. 
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Figure 2.6. Model of Meckel’s cartilage mineralization in the col11a1a morphant. 
The organized chondrocytes (green) serve as a template for bone forming cells (red) 
to generate a calcified matrix. These cells extend along the template and form two 
bilateral mineralized rods. Bone forming cells in the morphant have less template to 
serve as guide for the bone lining cells. Therefore, these cells cluster and produce 
abnormal mineralization at the cartilage template. 
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CHAPTER THREE: Col11a1 expression regulates the chondrocyte phenotype during 
chondrogenesis in ATDC5 cells 
Abstract 
Cartilage development is a tightly regulated process that involves multiple 
molecules. Therefore, the loss of expression of a single gene can alter cell behavior and 
disrupt the development of the cartilage. Col11a1 encodes the alpha one chain of the 
minor fibrillar collagen type XI that is essential in skeletal development. We used an 
RNAi mediated knockdown approach to investigate the role of Col11a1 expression 
during chondrogenesis in ATDC5 cells. We hypothesized that Col11a1 expression 
promotes the transition of mesenchymal cells to the chondrogenic phenotype, and that 
reduction of Col11a1 expression will delay or inhibit this transition. The results are 
consistent with a role for COL11A1 protein in the regulation of cell shape, matrix 
production, mineralization and gene expression through a mechanism that involves 
AKT/GSK3β/β-catenin and increases TCF/LEF activity during chondrogenesis. These 
data indicate an underappreciated role for COL11A1 protein in the regulation of cell 
behavior. 
Introduction 
Endochondral ossification requires that a cartilage template is formed prior to 
initiating ossification (Hall and Miyake 2000). The process of endochondral ossification 
is the primary bone forming mechanism during vertebrate development (Kronenberg 
2003). Therefore, successful vertebrate development requires the formation of a cartilage 
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template through chondrogenesis. To successfully form cartilage analgen, the cells must 
proceed through a series of maturation steps that begins with prechondrogenic 
mesenchymal cells forming a condensation and initiating the expression of genes 
involved in chondrocyte differentiation and matrix formation. The chondrocytes continue 
to mature and further differentiate into hypertrophic chondrocytes that contribute to 
matrix remodeling and ossification. The cells involved in this initial cartilage template 
remain in the growth plate and are responsible for longitudinal growth of the bone 
(Kronenberg 2003, Berendsen and Olsen 2015). Errors occurring during the formation of 
the cartilage can cause skeletal dysplasia or increase the susceptibility to the early onset 
of connective tissue diseases such as osteoarthritis. 
COL11A1 gene expression is essential for normal skeletal development, evident 
by diseases in humans and by the observation that mutations in the Col11a1 gene result 
in severe tissue disorganization in mice (Li et al. 1995, Hafez et al. 2015). 
Fibrochondrogenesis and Stickler’s syndrome type II are human skeletal dysplasias 
associated with mutations in the COL11A1 gene (Tompson et al. 2010a, Hufnagel et al. 
2014). Additionally, genetic alteration in COL11A1 contributes to intervertebral disc 
disease and degradation of the articular cartilage (Noponen-Hietala et al. 2003, Rodriguez 
et al. 2004, Raine et al. 2013). 
Collagen type XI is composed of three alpha chains, α1(XI), α2(XI), and α3(XI) 
(Morris and Bächinger 1987, Fernandes et al. 2007). Collagen type XI both nucleates 
fibril formation and regulates the fibril diameter (Blaschke et al. 2000, Gregory et al. 
2000, Holmes and Kadler 2006). The amino terminal domain of the α1(XI) chain is a 
unique domain to clade B fibrillar collagens that interacts with multiple extracellular 
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molecules, making it essential in providing integrity to the matrix network (Bernard et al. 
1988, Oxford et al. 2004, Warner et al. 2006, Brown et al. 2011). Despite our knowledge 
of the structural role of collagen type XI in the extracellular matrix of cartilage, the 
biological impact of COL11A1 gene mutations on cell behavior and molecular phenotype 
remain unknown. 
Previous studies have established the importance of COL11A1 protein in skeletal 
development, maintenance and health, but they have not investigated how decreased 
COL11A1 expression affects the chondroprogenitor cell behavior during chondrogenesis. 
The chondroprogenitors are derived from mesenchymal stem cells and their maturation 
into overt chondrocytes is a tightly regulated, sequential process (Goldring, Tsuchimochi, 
and Ijiri 2006). The chondrocytes undergo proliferation and upregulate chondrogenic 
gene expression of COL2A1, ACAN, and SOX9. These cells further change their 
expression to include upregulation of the hypertrophic chondrocyte markers COL10A1, 
RUNX2, and MMP13. Deviation from the normal expression pattern may alter the 
extracellular matrix environment permanently, causing chondrodysplasia and 
susceptibility to degenerative cartilage disease. Furthermore, cells interact with and react 
to the extracellular environment; therefore, dysplastic tissue has the potential to alter 
downstream cellular behaviors such as differentiation. In addition to nucleation and 
collagen fibril diameter, we propose the hypothesis that COL11A1 expression is required 
to promote chondroprogenitor cell maturation during endochondral ossification and 
chondrogenesis. Based on this hypothesis, we predict that skeletal dysplasia resulting 
from loss of COL11A1 expression alters chondrocyte phenotype and disrupts cell 
signaling events during chondrogenesis. 
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To test this hypothesis, we utilized the mouse ATDC5 chondrogenic cell line and 
induced differentiation using media containing insulin, transferrin, selenium (ITS), and 
ascorbic acid. ATDC5 cells are a well-established murine cell line used for studying the 
process of chondrogenesis and the transcriptome has been well documented (Chen et al. 
2005, Altaf et al. 2006, Yao and Wang 2013). To investigate the early role of Col11a1 in 
chondroprogenitor cells, we first identified the expression pattern of Col11a1 and then 
used an RNAi approach to inhibit the upregulation of Col11a1 during chondrocyte 
maturation. We analyzed the expression of chondrogenic markers in the knockdown cell 
culture as well as the activity of the β-catenin signaling pathway. We found that in the 
absence of Col11a1 expression, cellular morphology differed from control cultures. We 
also identified changes in the phosphorylation of AKT, GSK3β and β-catenin. The 
pattern of phosphorylation was consistent with the increased transcriptional activity of 
TCF/LEF and downstream gene expression. These results suggest that Col11a1 
expression mediates changes in cell phenotype by attenuating the β-catenin signaling 
pathway during chondrogenesis and endochondral ossification. 
Methods 
Cell Culture 
Mouse chondrogenic cell line ATDC5 cells were cultured in DMEM/F12 
containing 5% fetal bovine serum and 100 I.U./mL penicillin and 100 µg/mL 
streptomycin. Cells were passaged at 80% confluence by dissociating with 0.25% 
trypsin/EDTA for 3-5 mins at 37°C. For differentiation experiments, the culture media 
was replaced with differentiation media after the cells reached 100% confluency. 
Differentiation media was DMEM:F12 supplemented with Insulin (10 µg/mL), 
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Transferrin (0.5 µg/mL) Selenium (0.0067 µg/mL) (ITS, Gibco) and 50 µg/mL ascorbic 
acid 2-phosphate (A2P) (Wako Chemicals, USA). The differentiation media was replaced 
every other day for the duration of the experiment. 
Col11a1 Knockdown by Sirna Transfection 
ATDC5 cells were seeded in 6-well plates with 2.5 x 106 cells per well in culture 
media and allowed to reach 80-90% confluency prior to transfection. siRNA targeting 
Col11a1 was designed and purchased from Invitrogen. The 21-base pair double stranded 
siRNA was generated from interrogating RefSeq NM_007729.2 and targeting exon 2 at 
nucleotide location 590. Lipofectamine RNAiMAX was used for transfections following 
standard protocols. Transfections were performed in triplicate with a siRNA-lipid 
complex master mix prepared in Opti-MEM media. The final master mix solution 
contained 1 mL Opti-MEM, 10 µL of 10 µM siRNA stock and18 µL of Lipofectamine 
RNAiMAX. Control wells were transfected with negative control siRNA and performed 
in triplicate with each experiment under the same conditions as the experimental siRNA. 
BLOCK-iT Alexa Fluor Red Fluorescent Oligo was used to determine and optimize the 
transfection efficiency. A transfection efficiency of 90-100% was achieved when 
determined by monitoring uptake of the fluorescent oligonucleotide. Cell cultures 
recovered for 24 hours before changing the media to differentiation medium. 
3d Micromass Cultures 
Micromass cultures were generated by dissociating cells with 0.25% 
trypsin/EDTA from the wells and resuspending to 2.0 x 107 cells/mL in differentiation 
medium containing ITS and 50 µg/mL ascorbate 2-phosphate. Ten microliters of the cell 
suspension was gently spotted in tissue culture wells. The cells were allowed to adhere 
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for 2-3 hours in a tissue culture incubator at 37°C with 5% CO2 before adding additional 
medium. The medium was changed every other day for the duration of the experiment. 
Quantitative Rt-Pcr (Qpcr) Analysis 
RNA was extracted and purified using the RNAeasy minikit following 
manufacturer’s instructions (Qiagen). Isolated RNA was analyzed by spectrophotometry 
for purity and quantity and used immediately for cDNA synthesis or alternatively, 
aliquoted and stored at -80°C. RNA was reverse transcribed into cDNA using the RT2 
first strand kit. The cDNA template was analyzed by qRT-PCR reaction using Sybr 
Green and specific primers or directly in RT2 profiler PCR arrays in 96 well format. 
Reactions were carried using the Roche Lightcycler 96 target specific primers (Table 1). 
The relative amount of PCR product was normalized to the indicated reference genes and 
the change in threshold cycle (dCt) was compared using Student’s t-test. The fold change 
was calculated using the 2-ΔΔCt method (Schmittgen and Livak 2008) 
Luciferase Assays 
Cignal 45-pathway reporter array was used to identify changes in transcription 
factor activity following manufactures instructions. Lipofectamine 2000 was used with 
Opti-Mem to simultaneously reverse transfect Col11a1 siRNA and a mixture of 
transcription factor responsive firefly luciferase reporter and a constitutively expressing 
Renilla constructs. 5.0 x103 cells per well were added to each well of a 96-well plate 
containing 100 µL of transfection media containing 10 µM Col11a1 siRNA and 0.8 µL 
Lipofectamine 2000 per well. The cells were incubated at 37°C with 5% CO2 for 24 hours 
prior to changing the media to the indicated treatment. Dual luciferase reporter assay 
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system and Glomax multi detection system was used to measure the activity of the 
transcription factors following standard protocol. 
Western Blot Analysis 
Cell lysates were extracted using ice-cold radioimmunoprecipitation (RIPA) cell 
lysis buffer (ThermoFisher Scientific) supplemented with protease and phosphatase 
inhibitor cocktails added directly to the wells of six-well plates after washing with cold 
phosphate buffered saline (PBS). The cell lysates were collected and added to 
microcentrifuge tubes and the supernatant was cleared by centrifugation at 4°C, 14,000xg 
for 15 min and transferred to a new tube. Protein lysates were quantified using 
bicinchoninic (BCA) protein assay (Pierce). Proteins were separated by SDS PAGE and 
then transferred to nitrocellulose membranes for western blot analysis. SDS-PAGE gels 
were stained with coomassie blue to verified equal amounts of loading and transfer for 
each sample. Membranes were blocked using a 5% (w/v) non-fat milk solution in Tris-
buffered saline with 0.1% Tween-20, pH 7.4 (TBST) buffer for 1 hour at room 
temperature prior to incubation with primary antibodies. Primary antibodies were diluted 
in 5% (w/v) bovine serum albumin (BSA) in TBST prior to overnight incubation of the 
membranes at 4°C with shaking. Immunoblots were washed and then incubated with 
horseradish peroxidase (HRP) conjugated secondary antibodies for 1 hour at room 
temperature. Signal was detected using Pierce enhanced chemiluminescence (ECL) 
western blotting substrate. Western blots were performed using the following rabbit 
primary antibodies from Cell Signaling Technology at a dilution of 1:1000 unless 
otherwise stated: phospho-β-catenin (Ser33/37/Thr41), β-catenin (6B3) mAb, AKT, 
phospho-AKT (1:2000) (Ser473) (D9E) XP mAb, Gsk-3beta, phospho-GSK3-β (Ser9) 
53 
 
 
(5B3) mAb, β-Actin (13E5) mAb. Collagen type XI α1 chain specific rabbit polyclonal 
antibodies were designed to recognize epitopes within the amino propeptide (7990) or 
variable region 2 (1703) (Davies et al. 1998). 
Alcian Blue And Alizarin Red Staining 
Cells were differentiated for the indicated times and then stained with 0.1% 
Alcian blue 8GX in 1N HCl at 4°C overnight. For detection of matrix calcification, 
Alizarin Red solution (pH 4.2) was added for 5 min at room temperature and then washed 
with deionized water three times before imaging. 
Immunocytochemistry 
Cells were seeded on sterilized coverslips in 6-well plates in differentiation 
medium. Cells were fixed with 4% paraformaldehyde in PBS for 10 min at room 
temperature and washed 3 times with cold PBS. When required, permeabilization was 
performed by incubating samples for 10 min in 0.1% Triton X-100. Non-specific binding 
was blocked using 1% (w/v) BSA in PBS + 0.1% Tween20 (PBST) for 30 min at room 
temperature. Samples were incubated with diluted antibodies in 1% (w/v) BSA/PBST in 
a covered chamber overnight. Cells were incubated with secondary antibodies for 1 hour 
at room temperature in the dark. Counter stain for nuclei was performed by using Prolong 
gold anti fade mounting media with DAPI. 
Results 
Characterization Of Col11a1 And Chondrogenic Mrna Expression During 
Chondrogenesis In Atdc5 Cells 
We characterized the expression profile of the Col11a1 gene in the mouse 
chondrogenic ATDC5 cell line induced to differentiate with ITS and A2P (Figure 1). Day 
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0 of the experiment was designated as the time at which culture medium was exchanged 
for differentiation medium in confluent cultures. Using quantitative RT-PCR, we 
determined that Col11a1 mRNA was increased 7.6-fold at day 7 relative to day 0, and 
156-fold by day 14. We also demonstrated that Col11a1 mRNA levels significantly 
decreased between day 14 and 21 to 20% of the levels observed on day 14 (Figure 1A). 
Western blot analysis using two separate rabbit polyclonal antibody directed to the 
collagen α1(XI) chain amino terminal epitope or variable region 2 (V2) confirmed 
expression at each of the investigated time points (Figure 1B). Protein levels were 
detectable at day 0 and day 7 and in agreement with the mRNA levels, collagen α1(XI) 
chain protein reached maximally detectable levels in cell lysates by day 14. The protein 
detected on day 21 remained high despite the significant decrease in mRNA levels, a 
result that is not surprising given the long half-life on collagen proteins (Verzijl et al. 
2000, Toyama and Hetzer 2013). 
In addition to Col11a1, we confirmed the expression of chondrogenic 
differentiation markers in culture (Figure 1C). The expression patterns that we observed 
were consistent with previously reported results in ATDC5 cells using ITS and A2P to 
induce chondrogenic differentiation (Chen et al. 2005, Altaf et al. 2006). Col2a1 and 
Acan mRNA were increased at day 7 of differentiation. We did not observe significant 
changes in Sox9 mRNA between day 0 and 7 (Figure 1C). 
Col11a1 Knockdown Induces Fibroblast-Like Cytoskeletal Phenotype, Inhibits 
Cartilage Growth, And Increases Mineralization 
To investigate the requirement for Col11a1 expression during the transition of 
prechondrogenic cells to differentiated chondrocytes, we transfected ATDC5 cells with 
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double stranded siRNA complexes targeting Col11a1 mRNA. We optimized and verified 
the effectiveness of this approach by monitoring mRNA and protein levels in ATDC5 
cells. RNAi transfection prevented the increase in Col11a1 mRNA previously observed 
on day 7 (Figure 2). Expression on day 3 was decreased by 90% compared to negative 
control transfected cells and by more than 75% on day 7 (Figure 2A). Western blot 
analysis confirmed a decrease in total collagen α1(XI) chain protein levels in the cell 
lysates on day 7, although some protein was detectable (Figure 2B). Due to collagen’s 
long half-life, it is likely that the protein detected was translated prior to transfection with 
siRNA. New protein translation was blocked through RNAi degradation complexes as we 
could not detect collagen α1(XI) chain by immunofluorescence in transfected cells 
(Figure 2C). We observed changes in the actin cytoskeletal organization 3 days after 
Col11a1 siRNA transfection with cells appearing more elongated and fibroblast-like than 
control cells (Figure 2C). 
The development of the cartilage extracellular matrix can be determined by the 
presence of sulfated glycosaminoglycans in developing cartilage nodules. Additionally, 
late stage chondrogenesis is marked by increased matrix calcification. Micromass 
cultures transfected with Col11a1 siRNA and subsequently grown for 7 days produced 
less extracellular matrix than cells transfected with negative control siRNA as indicated 
by the decreased Alcian blue staining (Figure 3A and B). Additionally, increased 
mineralization was detectable in knockdown micromass cultures after 7 days in 
differentiation media (Figure 3C and D). 
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Inhibition Of Col11a1 Does Not Affect Genes Involved in Mesenchymal 
Condensation but Does Affect Genes Involved in Matrix Production and 
Remodeling 
The expression of mesenchymal condensation and stereotypical chondrogenic 
differentiation markers were analyzed by quantitative RT-PCR. Condensation of 
mesenchymal prechondrogenic cells is a prerequisite for chondrogenic differentiation and 
subsequent chondrocyte maturation. The expression of versican (Vcan), tenascin (Tnc), 
N-cadherin (Cdh2) and N-CAM (Ncam) are required for successful condensation to occur 
(Hall and Miyake 1995). The expression of Vcan, Tnc, Cdh2, and Ncam were unaffected 
by Col11a1 knockdown in ATDC5 cells (Figure 4). However, in the absence of Col11a1 
expression, the mRNA levels of collagen α1(II)chain (Col2a1) and matrix 
metallopeptidase-13 (Mmp13) were increased, while the expression of Sox9, Acan, and 
Col10a1 did not significantly change (Figure 5). 
To further investigate the link of between Col11a1 mRNA expression and 
cartilage development, we utilized a quantitative RT-PCR profiler array for extracellular 
matrix and adhesion genes. Consistent with our previous results, Mmp13 and Col2a1 
were upregulated in the assay. Additionally, Hyaluronan and Proteoglycan Link Protein 1 
(Hapln1), Connective tissue growth factor (Ctgf), Integrin beta 3 (Itgb3), Intercellular 
adhesion molecule 1 (Icam1), Laminin beta 3 (Lamb3), Laminin alpha 3 (Lama3) and 
collagen α3(IV)chain (Col4a3) were significantly increased by Col11a1 knockdown 
(Figure 6). 
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β-Catenin Signaling Pathway Activity is Increased When Col11a1 Expression is 
Inhibited During Chondrogenesis and is Independent of Wnt Induction 
Wnt/β-catenin signaling and the regulation of TCF/LEF transcriptional activity is 
essential in the development of the cartilage (Tamamura et al. 2005, Dao et al. 2012). 
Unregulated activity in cells of the chondrocyte lineage negatively influence tissue 
morphogenesis and consequently leads to disease (Usami et al. 2016). GSK3β is a 
constitutively expressed, multifunction, protein kinase involved in a variety of cellular 
mechanisms, including homeostasis of the cartilage (Doble and Woodgett 2003, Miclea 
et al. 2011). Phosphorylation of GSK3β at serine 9 uniquely inhibits the molecules kinase 
activity (Doble and Woodgett 2003, Kawasaki et al. 2008). Active GSK3β can 
phosphorylate β-catenin when in complex with Axin2, leading to the degradation and a 
decrease in the cytoplasmic levels (Aberle et al. 1997, Delcommenne et al. 1998). 
GSK3β is phosphorylated at Serine 9 in response to stimuli that include Wnt3a 
and insulin. Inhibition of Col11a1 expression increased the phosphorylation of GSK3β at 
serine 9 and decreased amino terminal β-catenin phosphorylation (Figure 7A). 
Interestingly, we also identified increased AKT phosphorylation at serine 473 in the 
absence of insulin. In addition to changes in AKT, GSK3βand β-catenin phosphorylation, 
we observed increased TCF/LEF activity when measured by luciferase assay with the 
TOP:FLASH reporter construct (Figure 7B). β-Catenin levels and localization fluctuate 
with cell behavior, gene expression and activation of cell signaling pathways. To identify 
changes in cell shape and localization of β-catenin caused by Col11a1 expression we 
used immunofluorescence microscopy. Actin fibers in control cells had a cortical actin 
pattern consistent with a chondrocyte phenotype. In contrast, inhibition of Col11a1 
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expression prevented cortical actin and favored cell spreading. Additionally, β-catenin 
was localized more perinuclear and β-catenin appeared throughout the cytoplasm of the 
cell (Figure 8). Stimulation of the canonical Wnt signaling pathway with recombinant 
Wnt3a protein was not inhibited by Col11a1 knockdown as indicated by substantial 
GSK3β phosphorylation and decreased β-catenin phosphorylation in both the negative 
control and Col11a1 siRNA samples. 
Discussion 
This is the first demonstration of a link between the extracellular matrix protein 
collagen α1(XI) chain and the activation of the AKT/GSK3β/β-catenin pathway during 
skeletal development. This cell culture model system provides a means by which to ask 
cellular questions relevant to chondrodysplasia in vitro. These results support the 
hypothesis that Col11a1 expression is required for chondrocyte maturation during 
chondrogenesis and endochondral ossification. Mutations in the human COL11A1 gene 
cause severe chondrodysplasia, affecting bones that develop by endochondral 
ossification, including the craniofacial skeleton, long bones, and the vertebrae (Li et al. 
1995, Tompson et al. 2010a, Stevenson et al. 2012, Faletra et al. 2014, Hafez et al. 2015). 
Although the shape and structure of skeletal tissues impacted by COL11A1 mutations 
have been described radiologically and at the ultrastructural level, the response of the 
cells to the altered matrix have not been fully characterized (Fernandes et al. 2007). Since 
the cells are ultimately responsible for both generating and maintaining tissues, 
understanding the consequences of the absence or reduction of COL11A1 expression has 
important ramifications for skeletal development, disease progression and therapies. We 
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hypothesize that COL11A1 expression is required for mesenchymal, prechondrogenic 
cells to transition to mature chondrocytes. 
In this study, we investigated the relationship between chondrocyte phenotype 
and the expression of Col11a1 using a mouse cell culture model system. We inhibited the 
expression of Col11a1 during chondrogenesis by transfecting prechondrocytes with 
siRNA targeting Col11a1 mRNA prior to inducing differentiation with ITS and ascorbate 
2-phosphate (A2P). The siRNA prevented the normal upregulation of Col11a1 
expression, thus creating a cell culture model system in which to investigate the effects of 
COL11A1 protein deficiency on chondroprogenitor maturation during cartilage 
development. We found that cells maintain a mesenchymal morphology, reduce matrix 
production, alter gene expression and activate AKT/GSK3β/β-catenin pathway in the 
absence of Col11a1 expression. Based on these results we propose that Col11a1 
expression attenuates β-catenin signaling in chondroprogenitor cells to regulate 
chondrocyte maturation and endochondral ossification. 
Collagen type XI’s role in skeletal development has previously been described as 
a structural constituent regulating collagen nucleation and fibril diameter. Additionally, 
Col11a1 expression in cell culture models, including ATDC5 cells, has been used to 
identify cells as having a chondrocyte phenotype (Davies et al. 1998, Chen et al. 2005). 
This study clearly supports that Col11a1 is expressed in chondrogenic cells during 
chondrogenesis and agrees with the hypothesis that Col11a1 expression is essential for 
skeletal development (Li et al. 1995). In addition to being a chondrocyte marker, the 
results of this study are consistent with the idea that Col11a1 is an early mediator of 
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chondrogenesis required to establish the overt chondrocyte phenotype from a 
mesenchymal prechondrocyte and provides a plausible and testable mechanism. 
Mutations in the COL11A1 gene cause the severe skeletal dysplasia, 
Fibrochondrogenesis. Skeletal development is severely affected in Fibrochondrogenesis, 
causing craniofacial defects such as micrognathia and long bone defects with flared 
metaphysis attributed to disorganization of the growth plate (Eteson et al. 1984, Whitley 
et al. 1984, Tompson et al. 2010). Additionally, the cartilage of the larynx is often weak 
and causes respiratory distress which is ultimately lethal. These morphological 
descriptions support COL11A1’s role to promotes cell shape, behavior and cartilage 
growth. The results presented in this study suggest that the inability of cells to stabilize 
the cell shape and cortical actin may prevent the necessary cell behavior from occurring 
during chondrogenesis. For example, cell-cell interactions requiring N-cadherin and β-
catenin promote cell shape, prechondrogenic cell condensations, and regulate Wnt 
signaling (Komori et al. 1997, Modarresi et al. 2005, Gao et al. 2010, Marie et al. 2014). 
Down regulation of these cell adhesions in favor of matrix-cell interactions is an essential 
step in chondrogenesis. Therefore, the inability of cells to establish stable cell-cell 
adhesions or transition to cell-matrix interactions may cause changes at the cellular level 
consistent with Col11a1 associated chondrodysplasia in mouse. 
The observed increases in mineralization may be due to accelerated hypertrophic 
differentiation or cartilage calcification in the absence of intermediate steps. 
Phosphorylation of GSK3β has previously been shown to promote hypertrophic 
differentiation (Kawasaki et al. 2008). Hypertrophic chondrocytes are a normal part of 
the endochondral ossification pathway and are required to initiate mineralization in the 
61 
 
 
growth plate under normal conditions (Ballock et al. 1993, Vega et al. 2004). On the 
other hand, premature initiation of the hypertrophic differentiation program has 
detrimental effects on the cartilage growth and integrity (van der Kraan and van den Berg 
2012, Jayasuriya et al. 2014). Additionally, hypertrophic chondrocytes can potentially 
transdifferentiate into osteoblasts during normal endochondral ossification (Yang et al. 
2014). 
Interestingly, we found that increased expression of Col2a1 and Mmp13 occurs in 
the absence of the collagen α1(XI) chain. These results indicate that the expression of 
Col2a1 and Mmp13 is dependent on collagen α1(XI) through an unidentified genetic 
network. The upregulation of Mmp13 was previously described in the articular cartilage 
of chondrodysplasia (cho) mouse with heterozygous null mutation in Col11a1 (Xu et al. 
2003, 2010). The researchers proposed that increased Mmp13 expression degraded the 
pericellular matrix and exposed chondrocyte discoidin domain-2 receptor (DDR2) to 
interact with the surrounding matrix, mainly collagen type II. The changes in gene 
expression in this study agree with their hypothesis. 
It is relevant to explain that the Col2a1 mRNA transcripts detected in our assays 
were total Col2a1 mRNA, and could not account for alternative splicing; therefore, it is 
possible that the increase in Col2a1 mRNA is primarily Col2a1 containing exon 2, which 
is highly expressed in mesenchymal cells. In contrast Col2a1 transcripts lacking exon 2 
are primarily found in differentiated chondrocytes (Hering et al. 2014; McAlinden et al. 
2008; Sandell et al. 1991; Sandell, et al. 1994). Future assays will utilize this unique 
splicing pattern to further understand the cellular phenotype involved in Col11a1 
expression. 
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The genes Hapln1, Ctgf, and Itgb3 each have essential roles in tissue 
morphogenesis and cartilage development and were upregulated by Col11a1 knockdown. 
Hapln1 is essential member of the cartilage matrix whose expression stabilizes aggrecan 
and hyaluronan links (Yamada and Watanabe 1999). Hapln1 overexpression has recently 
been linked to mesenchymal stem cell phenotype associated with the expression of β-
catenin (Mebarki et al. 2016). Ctgf is involved in both insulin mediated AKT/GSK3β 
signaling and hypertrophic chondrocyte differentiation (Nishida et al. 2003, Zhou et al. 
2008, Huang, Brugger, and Lyons 2010, Oh et al. 2016). Additionally, the up regulation 
of Itgb3, which along with the ItgaV protein subunit, interacts with the IGF-1 receptors 
enhances AKT signaling (Saegusa et al. 2009). In agreement with the changes in gene 
expression, we observed that AKT and GSK3β phosphorylation was increased in the 
absence of COL11A1 protein in ATDC5 cells and that TCF/LEF activity was increased 
overall. A previous study found that GSK3β inhibition in the cartilage induces cartilage 
degradation and decreases glycosaminoglycan detection (Miclea et al. 2011). 
Interestingly, inhibition of GSK3β was recently shown to increase the volume of 
trabecular bone (Arioka et al. 2013, Tatsumoto et al. 2016). Additionally, GSK3β 
inhibitors enhanced fracture healing by altering the mineralization pattern and skipping 
the formation of a cartilage template (Sisask et al. 2013). Consistent with these findings, 
we have observed in previous studies, that COL11A1 protein deficiency alters 
mineralization patterns, increase bone collar thickness and leads to wider trabecular 
structures, yet this is the first time we have implicated chondroprogenitor cells in the 
process of calcification (Kahler et al. 2008, Hafez et al. 2015). 
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RNA silencing using siRNA knockdown has limitations in that it may not 
completely degrade all target mRNA and expression may recover over time. We 
confirmed the stability of the knockdown using quantitative RT-PCR, western blot 
analysis and immunofluorescence microscopy. Because of the transient nature of the 
mRNA silencing, this study focused on expression occurring within the first week of 
culture. Differentiation was accelerated by including ITS and ascorbate 2-phosphate in 
the medium. This in vitro model provides insight into the cellular response to altered 
cartilage matrix induced by genetic defects in chondrocytes, yet cannot provide valuable 
information concerning neighbor tissue interactions. 
This work suggests that we may be able to rescue the COL11A1 protein 
deficiency by modulating AKT, GSK3β, or β-catenin activity in mouse. Future directions 
will improve upon the understanding of the relationship between human COL11A1 and 
AKT/GSK3β/β-catenin. Future studies will include activators and inhibitors of these cell 
signaling intermediates in cell culture and animal model systems. COL11A1 gene defects 
are also associated with intervertebral disc degeneration and osteoarthritis and may 
induce similar cellular responses. Additionally, questions regarding the roles of the other 
collagen type XI and V alpha chains as well as alternative spliced forms of collagen 
α1(XI) remain to be investigated. This information may lead to development of cell based 
and tissue regeneration therapies for surgical intervention or fracture healing. 
The requirement for Col11a1 gene expression to establish the chondrocyte 
phenotype during cartilage development is presented here. We show that although 
considered a structural protein, loss of Col11a1 gene expression impacts cellular behavior 
and cell signaling pathways. Undoubtedly the mechanisms influencing the cell behavior 
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are diverse and complex and therefore we are unlikely to isolate a single factor 
responsible for any deviations in behavior and function. Yet, understanding the cell 
phenotype at a particular stage provides the opportunity for investigation of cell targeted 
therapies. 
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Figure 3 1. Col11a1 gene expression during chondrogenesis in ATDC5 cells. 
Differentiation media was added to confluent cell cultures at day 0. Quantitative RT-
PCR was performed to detect Col11a1 mRNA in ATDC5 during chondrogenesis (A). 
Western blot analysis using two polyclonal antibodies that recognize unique epitopes 
were used to detect protein expression over the same time course (B). Col11a1 mRNA 
expression correlates with the expression of established chondrogenic markers Sox9, 
Col2a1, and Acan (C). Data is represented as mean and the standard deviation. 
Significance was determined using the t-test, n=3 *p < 0.05, **p<0.005, ***p < 0.0005.   
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Figure 3 2. Col11a1 knockdown causes fibroblast-like actin organization. qRT-
PCR was used to quantify the decrease of Col11a1 mRNA and protein 7 days after 
siRNA transfection. Col11a1 mRNA was decreased to 0.24 ± 0.03, N=3, relative to 
negative control siRNA transfections at day 7 (A). Protein levels detected using 
COL11A1 polyclonal antibody show a decrease in COL11A1 protein. Beta actin used 
to demonstrate equal loading per lane (B). Immunofluorescence detecting COL11A1 
protein (red) and actin (green) verify the loss of detectable COL11A1 protein and 
changes in the actin cytoskeleton at 3-days post transfection. Scale bar in is 20 µm. 
Data is represented as mean and SD., data analyzed using the t-test, **p < 0.005.  
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Figure 3 3. Knockdown of Col11a1 expression decreases the area of Alcian blue 
staining and increases Alizarin Red staining. Alcian blue staining was used to 
quantify the proteoglycan production in 7 day micromasses. Col11a1 siRNA 
decreases the relative area of proteoglycans detected (A and B). Surface area maps 
provide a visual representation of the staining intensity and shape. An opposite trend 
was observed when staining for calcium with Alizarin Red in micromass cultures. The 
relative area and intensity increased in the micromass. (C and D). 
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Figure 3 4. COL11A1 expression is not required for the expression of cellular 
condensation markers during chondrogenesis in ATDC5 cells. The mRNA expression 
of Ncam, Vcan, Tnc, and Cdh2 were not significantly altered in response to COL11A1 
knockdown during chondrogenesis. Data were analyzed using an unpaired t-test and 
represented as the mean with the standard deviation (n=3).   
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Figure 3 5. The expression of Col2a1 and Mmp13 are regulated by Col11a1 
knockdown. ATDC5 cells were transfected with either Neg siRNA or Col11a1 siRNA 
prior to chondrogenic differentiation. Expression of Sox9, Acan, and Col10a1 mRNA 
was not significantly different following inhibition of Col11a1 expression. Col2a1 and 
Mmp13 mRNA expression was significantly increased by the inhibition of Col11a1 
expression. Data were analyzed using the unpaired t-test and represented as the mean 
with the standard deviation (n=3). *=P-value <0.05, **<0.005, ***<0.0005.  
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Figure 3 6. Extracellular matrix and adhesion gene transcription is regulated by 
Col11a1 expression levels. Changes in mRNA expression levels were determined by 
comparing the expression level of mRNA for each target gene relative to β-actin. The 
relative expression of the Col11a1 siRNA transfected cells was compared to the 
negative control siRNA transfected cells. The fold change was calculated using the 2-
ΔΔCt method. The data were analyzed using unpaired t-test and represented as the 
mean and standard deviation (n=3). *=P-value <0.05, **<0.005, ***<0.0005.  
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Figure 3 7. Col11a1 knockdown increases AKT/GSK3β/β-catenin signaling 
activity and increases TCF/LEF activity. Col11a1 siRNA treatment increased the 
phosphorylation of GSK3β while decreasing phosphorylation levels of β-catenin (A). 
Additionally, Col11a1 siRNA induced phosphorylation of AKT at serine 473 (B). 
The activity of the TCF/LEF transcription factor was significantly increased relative 
to negative control siRNA transfected cells. (C).   
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Figure 3 8. Immunofluorescence imaging of the actin cytoskeleton and β-catenin 
localization. Increased cell spreading and increased β-catenin nuclear localization 
was found following Col11a1 knockdown. Immunofluorescence of the actin 
cytoskeleton (green) shows cortical actin in Neg Ctl siRNA transfected cells (A) and 
an increase in actin stress fibers and increased cell spreading in cells transfected with 
Col11a1 siRNA (B). β-catenin (red) is primarily perinuclear in the Neg Ctl transfected 
cells (A) and is present throughout the cytoplasm and localized to the nucleus. (B). 
Scale bars are 20 µm. 
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Figure 3 9  Inhibition of Col11a1 expression does not prevent Wnt3a induced 
phosphorylation of GSK3β or inhibition of β-catenin phosphorylation. The addition 
of 100 ng/mL of recombinant Wnt3a induced phosphorylation of GSK3B and 
inhibited β-catenin phosphorylation. 
  
74 
 
 
 
 
Figure 3 10. Model of β-catenin signaling in the absence of Col11a1 expression. In 
the absence of Wnt or under low Wnt conditions GSK3β phosphorylates β-catenin 
and leads degradation, keeping cytoplasmic levels low and preventing nuclear 
translocation. High levels of Wnt lead to receptor complexes that recruits GSK3β 
away from β-catenin and leads to GSK3β phosphorylation and subsequent 
accumulation of B-catenin and increased TCF/LEF activity. Inhibition of Col11a1 
expression creates a high Wnt like situation where the cells responds to low Wnt levels 
with increased TCF/LEF activity, decreased β-catenin phosphorylation and increased 
GSK3β phosphorylation. Collagen α1(XI) chain may prevent Wnt receptor 
complexes from forming and therefore aberrantly activating β-catenin signaling 
pathways. 
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Table 3.1 Table of Primers used for RT-PCR 
Target Forward Sequence Reverse Sequence 
Mouse 
Col2a1 
ACGAAGCGGTGGCAACCTCA CCCTCGGCCCTCATCTCTACATCA 
Mouse 
HPRT 
CTGGTGAAAAGGACCTCTCGAA 
 
CTGAAGTACTCATTATAGTCAAGGGCAT 
 
Mouse 
PPIA 
CGCGTCTCCTTCGAGCTGTTTG 
 
TGTAAAGTCACCACCCTGGCACAT 
 
Mouse 
Col10a1 
TGCCCGTGTCTGCTTTTACTGTCA 
 
TCAAATGGGATGGGGGCACCTACT 
 
Mouse 
Sox9 
GAGGCCACGGAACAGACTCA 
 
CAGCGCCTTGAAGATAGCATT 
 
Mouse 
Acan 
CCTCGGGCAGAAGAAAGA 
 
GTCTCATGCTCCGCTTCTGT 
 
Mouse 
Mmp13 
AGTTGACAGGCTCCGAGAAA GGCACTCCACATCTTGGTTT 
Mouse 
Col11a1 
TGGAAACCCACACCGGAAA TGCCTCTGTTTGTGCTACTGT 
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